The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Forbion Growth Management B.v. since 2024.
This trader's CIK number is 1918318.
At the time of last reporting, Forbion Growth Management B.v. was the Officer of Newamsterdam Pharma Co N.v.. (stock ticker symbol NAMS).
Also see all insider trading activities at Newamsterdam Pharma Co N.v..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | NAMS | 0 | $0 | 979,465 | $25,269,632 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ENGN | 1,032,430 | $8,016,774 | 0 | $0 | 0 | $0 |
1. Newamsterdam Pharma Co N.v. (NAMS)
2. Engene Holdings Inc. (ENGN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-18 | NAMS | Sale | 100,728 | 26.13 | 2,632,324 |
| 2024-12-19 | NAMS | Sale | 56,506 | 25.45 | 1,437,795 |
| 2024-12-16 | NAMS | Sale | 1,096 | 25.00 | 27,400 |
| 2024-12-17 | NAMS | Sale | 114,384 | 26.02 | 2,976,729 |
| 2024-12-12 | NAMS | Sale | 166,011 | 25.71 | 4,268,640 |
| 2024-12-13 | NAMS | Sale | 25,751 | 25.01 | 644,058 |
| 2024-12-11 | NAMS | Sale | 154,038 | 26.26 | 4,044,883 |
| 2024-12-10 | NAMS | Sale | 308,250 | 25.68 | 7,917,401 |
| 2024-11-15 | NAMS | Sale | 8,530 | 25.02 | 213,437 |
| 2024-11-18 | NAMS | Sale | 33,273 | 25.08 | 834,453 |
| 2024-11-13 | NAMS | Sale | 1,066 | 25.00 | 26,654 |
| 2024-11-14 | NAMS | Sale | 9,832 | 25.01 | 245,858 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-10-30 | ENGN | Buy | 561,797 | 8.90 | 4,999,993 |
| 2024-10-07 | ENGN | Buy | 11,844 | 6.55 | 77,530 |
| 2024-09-30 | ENGN | Buy | 341,332 | 6.34 | 2,163,362 |
| 2024-09-27 | ENGN | Buy | 41,639 | 6.16 | 256,454 |
| 2024-10-04 | ENGN | Buy | 5,997 | 6.54 | 39,244 |
| 2024-10-03 | ENGN | Buy | 5,769 | 6.48 | 37,394 |
| 2024-10-02 | ENGN | Buy | 10,153 | 6.37 | 64,694 |
| 2024-10-01 | ENGN | Buy | 35,279 | 6.44 | 227,161 |
| 2023-12-29 | ENGN | Buy | 10,020 | 8.70 | 87,123 |
| 2023-12-28 | ENGN | Buy | 5,050 | 7.69 | 38,829 |
| 2023-12-27 | ENGN | Buy | 2,750 | 7.17 | 19,712 |
| 2024-10-08 | ENGN | Buy | 800 | 6.60 | 5,278 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Forbion Growth Management B.v. (Officer of Newamsterdam Pharma Co N.v. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.